Tetra Bio Pharma Inc T.TBP

Primary Symbol: TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Tetra is broke and Reduvo will not save the scamming CEO

<< Previous

Bullboard Posts

Next >>

Comment by Realnewsalways1on Aug 15, 2022 1:09pm

140 Views

Post# 34896910

RE:Tetra is broke and Reduvo will not save the scamming CEO

spreading half truths as usual...the company does not owe 140m...those are accumulated losses. FOOL. $500mil to take it over finish line another lie. but it will take a few million. wrong again about your raise at .05 another conjecture which is again wrong....time to go bud take your valuable time and use it somewhere else.

<< Previous

Bullboard Posts

Next >>

Honda to build Canada’s first EV supply chain for C$15 billion